Insulin resistance in depressive disorders and Alzheimer's disease: Revisiting the missing link hypothesis

Neurobiology of Aging

Volumn 26, Issue SUPPL., 2005, Pages 103-107

  Rasgon, Natalie L ^a   Kenna, Heather A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Depression; Depressive disorders; Insulin resistance

Indexed keywords

ALZHEIMER DISEASE; BRAIN REGION; COGNITIVE DEFECT; CONFERENCE PAPER; DEPRESSION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; LIMBIC SYSTEM; NERVE DEGENERATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RADIATION SICKNESS; WEIGHT GAIN;

EID: 28444488872     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.09.004     Document Type: Conference Paper

References (47)

1. N. Awad, M. Gagnon, and C. Messier The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function J Clin Exp Neuropsychol 26 8 2004 1044 1080
2. L. Baxter, M. Phelps, and J. Mazziotta Cerebral metabolic rates for glucose in mood disorders Arch Gen Psychiatry 42 1985 441 447
3. P. Bjorntorp, G. Holm, and R. Rosmond Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus Diabet Med 16 5 1999 373 383
4. R. Bonadonna, L. Groop, N. Kraemer, E. Ferrannini, S. Del Prato, and R. DeFronzo Obesity and insulin resistance in humans: a dose-response study Metabolism 39 5 1990 452 459
5. A. Brody, S. Saxena, M. Mandelkern, L. Fairbanks, M. Ho, and L. Baxter Brain metabolic changes associated with symptom factor improvement in major depressive disorder Biol Psychiatry 50 2001 171 178
6. W. Bruce-Jones, G. Zolese, and P. White Poly cystic ovary syndrome and psychiatric morbidity J Psychosom Obstet Gynaecol 14 2 1993 111 116
7. H. Cannon-Spoor, J. Levy, G. Zubenko, W. Zubenko, R. Cohen, and N. Mirza Effects of previous major depressive illness on cognition in Alzheimer disease patients Am J Geriatr Psychiatry 13 4 2005 312 318
8. P. Chen, M. Ganguli, B. Mulsant, and S. DeKosky The temporal relationship between depressive symptoms and dementia: a community-based prospective study Arch Gen Psychiatry 56 3 1999 261 266
9. B. Cheng, and M. Mattson IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage J Neurosci 12 1992 1558 1566
10. M. Chiba, S. Suzuki, Y. Hinokio, M. Hirai, Y. Satoh, and A. Tashiro Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder Metabolism 49 9 2000 1145 1149
11. B. Cooper, and C. Holmes Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study Age Ageing 27 1998 181 188
12. T. den Heijer, S. Vermeer, E. van Dijk, N. Prins, P. Koudstaal, and A. Hofman Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI Diabetologia 46 12 2003 1604 1610
13. W. Drevets, D. Ongur, and J. Price Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for pathophysiology of familial mood disorders Mol Psychiatry 3 1998 220 226
14. C. Enzinger, F. Fazekas, P. Matthews, S. Ropele, H. Schmidt, and S. Smith Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects Neurology 64 10 2005 1704 1711
15. C. Gillespie, and C. Nemeroff Hypercortisolemia and depression Psychosom Med 67 Suppl. l 2005 S26 S28
16. P. Gold, G. Chrousos, C. Kellner, R. Post, A. Roy, and P. Augerinos Psychiatric implications of basic and clinical studies with corticotropin- releasing factor Am J Psychiatry 141 5 1984 619 627
17. P. Gold, P. Martinez, A. Haim, F. Eskandari, G. Cizza, and S. Alesci Decreased insulin sensitivity and increased plasma insulin, glucose, and triglyceride concentrations and their interactions in remitted patients with major depression: evidence for an incipient metabolic syndrome Society of Biological Psychiatry 60th Annual Scientific Convention and Meeting Atlanta, GA 2005
18. F. Gonzalez Adrenal involvement in polycystic ovary syndrome Semin Reprod Endocrinol 15 2 1997 137 157
19. B. Gupta, A. Awasthi, and B. Jaju Effect of acute and chronic imipramine treatment on glucose homeostasis Indian J Med Res 96 1992 65 71
20. D. Horrobin, and C. Bennett New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism Prostaglandins Leukot Essent Fatty Acids 60 1999 141 167
21. S. Hoyer, N Henneberg, S. Knapp, H. Lannert, and E. Martin Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor Ann NY Acad Sci 777 1996 374 379
22. T. Ketter, M. Frye, G. Cora-Locatelli, T. Kimbrell, and R. Post Metabolism and excretion of mood stabilizers and new anticonvulsants Cell Mol Neurobiol 19 4 1999 511 532
23. D. Kopf, S. Westphal, C. Luley, S. Ritter, M. Gilles, and B. Weber-Hamann Lipid metabolism and insulin esistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment J Clin Psychopharmcol 24 5 2004 527 531
24. G. Kyriaki Brain insulin: regulation, mechanisms of action and functions Cell Mol Neurobiol 23 1 2003 1 25
25. J. Luchsinger, and R. Mayeux Cardiovascular risk factors and Alzheimer's disease Curr Atheroscler Rep 6 4 2004 261 266
26. J. Luchsinger, M. Tang, S. Shea, and R. Mayeux Hyperinsulinemia and risk of Alzheimer disease Neurology 63 7 2004 1187 1992
27. S. McElroy, R. Kotwal, S. Malhotra, E. Nelson, P. Keck, and C. Nemeroff Are mood disorders and obesity related? A review for the mental health professional J Clin Psychiatry 65 5 2004 634 651
28. T. McLaughlin, G. Allison, F. Abbasi, C. Lamendola, and G. Reaven Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals Metabolism 53 4 2004 495 499
29. C. Messier Diabetes, Alzheimer's disease and apolipoprotein genotype Exp Gerontol 38 9 2003 941 946
30. S. Moffat, C. Szekely, A. Zonderman, N. Kabani, and S. Resnick Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype Neurology 55 1 2000 134 136
31. J. Morrison, E. Cottingham, and B. Barton Metformin for weight loss in pediatric patients taking psychotropic drugs Am J Psychiatry 159 2002 655 657
32. F. Okamura, A. Tashiro, A. Utumi, T. Imai, T. Suchi, and D. Tamura Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis Metabolism 49 10 2000 1255 1260
33. R. Palovcik, M. Phillips, M. Kappy, and M. Raizada Insulin inhibits pyramidal neurons in hippocampal slices Brain Res 309 1984 187 191
34. R. Peila, B. Rodriguez, and L. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study Diabetes 51 4 2002 1256 1262
35. N. Rasgon, L. Altshuler, L. Fairbanks, S. Elman, J. Bitran, and R. Labarca Reproductive function and risk for PCOS in women treated for bipolar disorder Bipolar Disord 7 3 2005 246 259
36. N. Rasgon, M. Carter, S. Elman, M. Bauer, M. Love, and S. Korenman Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review Curr Drug Targets Immune Endocr Metabol Disord 2 1 2002 97 102
37. N. Rasgon, G. Jarvik, and L. Jarvik Affective disorders and Alzheimer disease: a missing-link hypothesis Am J Geriatr Psychiatry 9 4 2001 444 445
38. N. Rasgon, and L. Jarvik Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis J Gerontol A Biol Sci Med Sci 59 2 2004 178 183
39. N. Rasgon, R. Rao, S. Hwang, L. Altshuler, S. Elman, and J. Zuckerbrow-Miller Depression in women with polycystic ovary syndrome: clinical and biochemical correlates J Affect Disord 74 3 2003 299 304
40. Rasgon N, Reynolds M, Elman S, Saad M, Frye M, Bauer M. et al. Longitudinal evaluation of reproductive function in women treated for bipolar disorder. J Affect Disord, in press.
41. D. Sheps, and D. Sheffield Depression, anxiety, and the cardiovascular system: a cardiologist's perspective J Clin Psychiatry 62 Suppl. 8 2001 12 16
42. G. Small, L. Ercoli, D. Silverman, S. Huang, S. Komo, and S. Bookheimer Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease PNAS 97 11 2000 6037 6042
43. Watson G, Cholerton B, Reger M, Baker L, Plymate S, Asthana S, et al. Preserved cognition during rosiglitazone treatment in early Alzheimer's disease. Am J Geriatr Psychiatry, in press.
44. B. Weber, S. Lewicka, M. Deuschle, M. Colla, and I. Heuser Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression Psychoneuroendocrinology 25 8 2000 765 771
45. R. Williams, and M. Chesney Psychosocial factors and prognosis in established coronary artery disease. The need for research on interventions JAMA 270 1993 1860 1861
46. A. Winokur, G. Maislin, J. Phillips, and J. Amsterdam Insulin resistance after oral glucose tolerance testing in patients with major depression Am J Psychiatry 145 3 1988 325 330
47. H. Yen, A. Jakimiuk, I. Munir, and D. Magoffm Selective alterations in insulin receptor substrates-1,-2 and -4 in theca but not granulosa cells from polycystic ovaries Mol Hum Reprod 10 7 2004 473 479